US 10034893
5, 6-D2 uridine nucleoside/tide derivatives
granted A61KA61K31/13A61K31/7056
Quick answer
US patent 10034893 (5, 6-D2 uridine nucleoside/tide derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/13, A61K31/7056, A61K31/7072, A61K38/21